{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:19:55Z","timestamp":1790097595078,"version":"4.0.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nephrolithiasis is a common complication in autosomal dominant polycystic kidney disease (ADPKD), yet its impact on long-term kidney outcomes remains uncertain. Although experimental and retrospective studies suggest a potential role of kidney stones in accelerating disease progression, prospective evidence based on imaging-confirmed nephrolithiasis is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective cohort study included 410 patients with ADPKD from the HOPE-PKD cohort who underwent baseline abdominal computed tomography (CT) within 1 year of enrollment. Nephrolithiasis was defined as radiopaque lesions located within the collecting system, whereas cyst wall calcifications were excluded based on established CT criteria. The primary outcome was initiation of renal replacement therapy (RRT) due to kidney failure. The secondary outcome was a composite of \u226550% decline in estimated glomerular filtration rate, doubling of serum creatinine, or initiation of RRT. Multivariable Cox proportional hazards models were constructed with adjustment for demographic, metabolic, genetic, and imaging-based risk factors, including imaging-based risk stratification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a median follow-up of 5.18 years, 51 (12.4%) and 96 (23.4%) participants reached the primary and secondary endpoints, respectively. After adjustment for demographic, metabolic, and disease severity factors, the stone group showed a significantly higher risk of both the primary [Hazard ratio (HR) 2.84; 95% Confidence interval (CI) 1.26\u20136.38; P = .012] and secondary (HR 1.83; 95% CI 1.03\u20133.27; P = .041) endpoints compared with the no-stone group. Associations appear to be more pronounced in males, individuals with higher body mass index, worse baseline kidney function, larger kidney volume, and PKD1 genotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Imaging-confirmed nephrolithiasis is independently associated with adverse kidney outcomes in patients with ADPKD. Early detection and targeted management of kidney stones may improve risk stratification and kidney prognosis in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfag195","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:52:10Z","timestamp":1781092330000},"source":"Crossref","is-referenced-by-count":1,"title":["Association between nephrolithiasis and kidney disease progression in patients with autosomal dominant polycystic kidney disease: a prospective cohort study"],"prefix":"10.1093","volume":"19","author":[{"given":"Hongran","family":"Moon","sequence":"first","affiliation":[{"name":"Seoul National University College of Medicine Department of Internal Medicine, , Seoul ,","place":["Korea"]},{"name":"Seoul National University Hospital Department of Internal Medicine, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Chul","family":"Kim","sequence":"additional","affiliation":[{"name":"Seoul National University College of Medicine Department of Internal Medicine, , Seoul ,","place":["Korea"]},{"name":"Seoul National University Hospital Department of Internal Medicine, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayne Cho","family":"Park","sequence":"additional","affiliation":[{"name":"Hallym University Kangnam Sacred Heart Hospital Department of Internal Medicine, , Seoul ,","place":["Korea"]},{"name":"Kidney Research Institute, Hallym University College of Medicine , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital Department of Radiology, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yong","family":"Cho","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital, Seoul National University College of Medicine Department of Urology, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9525-2179","authenticated-orcid":false,"given":"Kook-Hwan","family":"Oh","sequence":"additional","affiliation":[{"name":"Seoul National University College of Medicine Department of Internal Medicine, , Seoul ,","place":["Korea"]},{"name":"Seoul National University Hospital Department of Internal Medicine, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curie","family":"Ahn","sequence":"additional","affiliation":[{"name":"National Medical Center Department of Nephrology, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Ryu","sequence":"additional","affiliation":[{"name":"Seoul National University Hospital Department of Internal Medicine, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8632-5743","authenticated-orcid":false,"given":"Yun Kyu","family":"Oh","sequence":"additional","affiliation":[{"name":"Seoul National University College of Medicine Department of Internal Medicine, , Seoul ,","place":["Korea"]},{"name":"Seoul Metropolitan Government Seoul National University Boramae Medical Center Department of Internal Medicine, , Seoul ,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"2026070911282522300_bib1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: improving global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"key":"2026070911282522300_bib2","doi-asserted-by":"publisher","first-page":"2054358120934628","DOI":"10.1177\/2054358120934628","article-title":"Stone prevalence in autosomal dominant polycystic kidney disease: a systematic review and meta-analysis","volume":"7","author":"Kalatharan","year":"2020","journal-title":"Can J Kidney Health Dis"},{"key":"2026070911282522300_bib3","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"2026070911282522300_bib4","doi-asserted-by":"publisher","first-page":"109648","DOI":"10.1016\/j.cellsig.2020.109648","article-title":"Molecular pathways involved in injury-repair and ADPKD progression","volume":"72","author":"Formica","year":"2020","journal-title":"Cell Signal"},{"key":"2026070911282522300_bib5","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2215\/CJN.00780110","article-title":"Renal function and healthcare costs in patients with polycystic kidney disease","volume":"5","author":"Lentine","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070911282522300_bib6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0272-6386(12)80922-X","article-title":"Renal stone disease in autosomal dominant polycystic kidney disease","volume":"22","author":"Torres","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"2026070911282522300_bib7","doi-asserted-by":"publisher","first-page":"3068365","DOI":"10.1155\/2018\/3068365","article-title":"Kidney stone disease: an update on current concepts","volume":"2018","author":"Alelign","year":"2018","journal-title":"Adv Urol"},{"key":"2026070911282522300_bib8","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12882-015-0126-1","article-title":"Impact of nephrolithiasis on kidney function","volume":"16","author":"Sigurjonsdottir","year":"2015","journal-title":"BMC Nephrol"},{"key":"2026070911282522300_bib9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2215\/CJN.03210312","article-title":"Urolithiasis and the risk of ESRD","volume":"7","author":"El-Zoghby","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070911282522300_bib10","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1172\/JCI128503","article-title":"Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease","volume":"129","author":"Torres","year":"2019","journal-title":"J Clin Invest"},{"key":"2026070911282522300_bib11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.34067\/KID.0000000000000524","article-title":"Kidney stone disease and progression risk in autosomal dominant polycystic kidney disease: a post hoc analysis of OVERTURE","volume":"5","author":"Gitomer","year":"2024","journal-title":"Kidney360"},{"key":"2026070911282522300_bib12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12882-025-03979-7","article-title":"The impact of asymptomatic kidney stones on disease progression in autosomal dominant polycystic kidney disease","volume":"26","author":"Elcioglu","year":"2025","journal-title":"BMC Nephrol"},{"key":"2026070911282522300_bib13","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/nrurol.2016.154","article-title":"An overview of kidney stone imaging techniques","volume":"13","author":"Brisbane","year":"2016","journal-title":"Nat Rev Urol"},{"key":"2026070911282522300_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2024.07.009","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","author":"Kidney Disease: Improving Global Outcomes (KDIGO) ADPKD Work Group","year":"2025","journal-title":"Kidney Int"},{"key":"2026070911282522300_bib15","doi-asserted-by":"publisher","first-page":"16952","DOI":"10.1038\/s41598-019-52474-1","article-title":"Genetic characteristics of Korean patients with autosomal dominant polycystic kidney disease by targeted exome sequencing","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"2026070911282522300_bib16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2214\/ajr.159.1.1609726","article-title":"Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients","volume":"159","author":"Levine","year":"1992","journal-title":"AJR Am J Roentgenol"},{"key":"2026070911282522300_bib17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2026070911282522300_bib18","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026070911282522300_bib19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3904\/kjim.2021.176","article-title":"Clinical and genetic characteristics of Korean autosomal dominant polycystic kidney disease patients","volume":"36","author":"Oh","year":"2021","journal-title":"Korean J Intern Med"},{"key":"2026070911282522300_bib20","first-page":"2050","article-title":"Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease","volume":"8","author":"Bae","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070911282522300_bib21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1053\/ajkd.2000.8266","article-title":"Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease","volume":"36","author":"Grampsas","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2026070911282522300_bib22","doi-asserted-by":"publisher","first-page":"838","DOI":"10.2215\/CJN.03100608","article-title":"Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients","volume":"4","author":"Nishiura","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070911282522300_bib23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1053\/j.ackd.2015.04.004","article-title":"The new epidemiology of nephrolithiasis","volume":"22","author":"Shoag","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026070911282522300_bib24","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0272-6386(88)80137-9","article-title":"The association of nephrolithiasis and autosomal dominant polycystic kidney disease","volume":"11","author":"Torres","year":"1988","journal-title":"Am J Kidney Dis"},{"key":"2026070911282522300_bib25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.2215\/CJN.13861119","article-title":"Urinary lithogenic risk profile in ADPKD patients treated with Tolvaptan","volume":"15","author":"Bargagli","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026070911282522300_bib26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.3904\/kjim.2022.376","article-title":"Recent updates in therapeutic approach using tolvaptan for autosomal dominant polycystic kidney disease","volume":"38","author":"Kim","year":"2023","journal-title":"Korean J Intern Med"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfag195\/68513397\/sfag195.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/7\/sfag195\/68513397\/sfag195.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/19\/7\/sfag195\/68513397\/sfag195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:28:31Z","timestamp":1783610911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfag195\/8706393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfag195","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,6,11]]},"article-number":"sfag195"}}